Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: NICHD 2K12HD000849-28
NCI NIH HHS
Grant: T32 CA113275
National Institutes of Health
Grant: 1T32CA113275-01A1
Molecular Oncology Training Grant
National Institutes of Health
Grant: 5K12HD000849-12
REPRODUCTIVE SCIENTIST DEVELOPMENT PROGRAM
Fields of Study
Keywords
Sustainable Development Goals